These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7829441)

  • 41. Brain grafting as a treatment for Parkinson's disease.
    Perlow MJ
    Neurosurgery; 1987 Feb; 20(2):335-42. PubMed ID: 3550516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Transplantation of fetal dopaminergic cells simultaneously to the corpus striatum and pars reticularis of the substantia nigra in hemi-parkinsonian rats].
    Blanco L; Pavón N; Alvaŕez P; Díaz C; Castellano O; Castillo L; de la Cuétara K; Macías R
    Rev Neurol; 1998 Mar; 26(151):361-5. PubMed ID: 9585942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Halifax hospital first in Canada to proceed with controversial fetal-tissue transplant.
    Jones D
    CMAJ; 1992 Feb; 146(3):389-91. PubMed ID: 1544055
    [No Abstract]   [Full Text] [Related]  

  • 44. Reaction time and movement time after embryonic cell implantation in Parkinson disease.
    Gordon PH; Yu Q; Qualls C; Winfield H; Dillon S; Greene PE; Fahn S; Breeze RE; Freed CR; Pullman SL
    Arch Neurol; 2004 Jun; 61(6):858-61. PubMed ID: 15210522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Using fetal tissue.
    McFadden RA
    Sci Am; 1992 Dec; 267(6):10. PubMed ID: 1439708
    [No Abstract]   [Full Text] [Related]  

  • 46. [Parkinson disease: transplantation of embryonic brain tissue].
    Hirschelmann R
    Med Monatsschr Pharm; 1993 Sep; 16(9):274-6. PubMed ID: 8412978
    [No Abstract]   [Full Text] [Related]  

  • 47. [Cell transplantation in Parkinson disease].
    Lindvall O; Aquilonius SM
    Lakartidningen; 2001 Nov; 98(46):5193-5. PubMed ID: 11761572
    [No Abstract]   [Full Text] [Related]  

  • 48. Fetal homotransplants in the treatment of Parkinson's disease.
    Freeman TB; Olanow GW
    Arch Neurol; 1991 Sep; 48(9):900-2. PubMed ID: 1953410
    [No Abstract]   [Full Text] [Related]  

  • 49. Implantation of dopaminergic cells in the treatment of parkinsonism.
    Bagchi AK
    J Indian Med Assoc; 1993 Aug; 91(8):200. PubMed ID: 8245489
    [No Abstract]   [Full Text] [Related]  

  • 50. Prospects for Parkinson disease.
    Nat Med; 2001 Apr; 7(4):381. PubMed ID: 11283634
    [No Abstract]   [Full Text] [Related]  

  • 51. Brain transplants.
    Robinson RO
    Dev Med Child Neurol; 1983 Oct; 25(5):654-6. PubMed ID: 6354805
    [No Abstract]   [Full Text] [Related]  

  • 52. Are dyskinesias a problem after neural transplantation for Parkinson's disease?
    Bradbury J
    Lancet; 2002 Jun; 359(9322):2007. PubMed ID: 12076564
    [No Abstract]   [Full Text] [Related]  

  • 53. Neurotransplantation: a clinical update.
    Bakay RA
    Acta Neurochir Suppl (Wien); 1993; 58():8-16. PubMed ID: 8109310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Embryonic brain grafts in an animal model of Parkinson's disease. Criteria for human application.
    Freed WJ; Cannon-Spoor HE; Wyatt RJ
    Appl Neurophysiol; 1984; 47(1-2):16-22. PubMed ID: 6508277
    [No Abstract]   [Full Text] [Related]  

  • 55. Parkinson's disease. Signs of disease in fetal transplants.
    Miller G
    Science; 2008 Apr; 320(5873):167. PubMed ID: 18403684
    [No Abstract]   [Full Text] [Related]  

  • 56. Neuropsychological and behavioral aspects of transplants in Parkinson's disease and Huntington's disease.
    Diederich NJ; Goetz CG
    Brain Cogn; 2000 Mar; 42(2):294-306. PubMed ID: 10744925
    [No Abstract]   [Full Text] [Related]  

  • 57. Activation of neurotransplants in humans.
    Blüml S; Kopyov O; Jacques S; Ross BD
    Exp Neurol; 1999 Jul; 158(1):121-5. PubMed ID: 10448423
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disappointment for Parkinson's disease patients.
    Craven R
    Trends Pharmacol Sci; 2001 May; 22(5):221. PubMed ID: 11339966
    [No Abstract]   [Full Text] [Related]  

  • 59. Fetal mesencephalic transplantation for the treatment of Parkinson's disease.
    Tecnologica; 1995 Sep; ():7-8. PubMed ID: 10168298
    [No Abstract]   [Full Text] [Related]  

  • 60. Can graft-derived neurotrophic activity be used to direct axonal outgrowth of grafted dopamine neurons for circuit reconstruction in primates?
    Sladek JR; Collier TJ; Elsworth JD; Taylor JR; Roth RH; Redmond DE
    Exp Neurol; 1993 Nov; 124(1):134-9. PubMed ID: 8282070
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.